These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15115666)

  • 21. Assays to Monitor Bivalirudin.
    Davidson S
    Methods Mol Biol; 2023; 2663():369-380. PubMed ID: 37204724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors.
    Alouidor B; Sweeney RE; Tat T; Wong RK; Yoon JY
    J Extra Corpor Technol; 2019 Mar; 51(1):29-37. PubMed ID: 30936586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated partial thromboplastin time is more sensitive than ecarin clotting time for monitoring low doses of desirudin.
    Mazoyer E; Drouet L; Delahousse B; Gruel Y; Rouyrre N
    Thromb Res; 2002 May; 106(4-5):271-2. PubMed ID: 12297138
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
    Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender.
    Robson R; White H; Aylward P; Frampton C
    Clin Pharmacol Ther; 2002 Jun; 71(6):433-9. PubMed ID: 12087346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotational thrombelastometry for the bedside monitoring of recombinant hirudin.
    Sucker C; Zotz RB; Görlinger K; Hartmann M
    Acta Anaesthesiol Scand; 2008 Mar; 52(3):358-62. PubMed ID: 18205897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
    Brener SJ; Moliterno DJ; Lincoff AM; Steinhubl SR; Wolski KE; Topol EJ
    Circulation; 2004 Aug; 110(8):994-8. PubMed ID: 15302778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
    Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
    J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
    Tanaka KA; Szlam F; Sun HY; Taketomi T; Levy JH
    Anesth Analg; 2007 Oct; 105(4):933-9, table of contents. PubMed ID: 17898368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology.
    Ahrens I; Smith BK; Bode C; Peter K
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):609-20. PubMed ID: 17696810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.
    Borg S; Persson U; Allikmets K; Ericsson K
    Clin Ther; 2006 Nov; 28(11):1947-59. PubMed ID: 17213015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin.
    Keating FK; Dauerman HL; Whitaker DA; Sobel BE; Schneider DJ
    Thromb Res; 2006; 118(3):361-9. PubMed ID: 16139336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
    Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
    Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of three methods for measuring PEG-hirudin in blood.
    Hoffmann JJ; Janssen WC
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):577-81. PubMed ID: 11685047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ecarin-Based Methods for Measuring Thrombin Inhibitors.
    Gosselin RC
    Methods Mol Biol; 2023; 2663():355-367. PubMed ID: 37204723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.
    Merry AF; Raudkivi PJ; Middleton NG; McDougall JM; Nand P; Mills BP; Webber BJ; Frampton CM; White HD
    Ann Thorac Surg; 2004 Mar; 77(3):925-31; discussion 931. PubMed ID: 14992900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention.
    Sibbing D; Busch G; Braun S; Jawansky S; Schömig A; Kastrati A; Ott I; von Beckerath N
    Eur Heart J; 2008 Jun; 29(12):1504-9. PubMed ID: 18467322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass.
    Koster A; Chew D; Gründel M; Bauer M; Kuppe H; Spiess BD
    Anesth Analg; 2003 Feb; 96(2):383-6, table of contents. PubMed ID: 12538181
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature.
    Arora UK; Dhir M; Cintron G; Strom JA
    J Invasive Cardiol; 2004 Jun; 16(6):330-2. PubMed ID: 15156005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.
    Baker T; Chan R; Hill F
    J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.